Gerald E Quirk
CIK 1479603 · Chief Legal & Compliance Offic · last filed 2024-11-20
Gerald E Quirk is a Chief Legal & Compliance Offic who has filed 18 SEC Form 4 insider transactions across 3 companies since 2010. The most recent filing shows the insider sold $10.3K of SYRS on Nov 20, 2024. Across all open-market trades the lifetime net is −$10.3K, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
3
18
-$10.3K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SYRS | Chief Legal & Compliance Offic | 0 | $0.00 | $0 | -$10.3K | 13 | 2024-11-20 |
| Eledon Pharmaceuticals, Inc. (TKAI) Delisted | General Counsel, Executive VP | — | — | — | $0 | 2 | 2015-12-17 |
| INFINITY PHARMACEUTICALS, INC. (INFI) Delisted | See Remarks | — | $0.04 | — | $0 | 3 | 2012-01-09 |
Recent Filings
18 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-11-20 | SYRS | Sell (S) | −46,657 | -$10.3K | EDGAR |
| 2024-10-02 | SYRS | Mixed | +6,900 | -$6.5K | EDGAR |
| 2024-04-02 | SYRS | Mixed | +15,454 | -$39.4K | EDGAR |
| 2023-10-20 | SYRS | Mixed | +15,603 | -$14.5K | EDGAR |
| 2023-09-14 | SYRS | Grant (A) | — | $0 | EDGAR |
| 2022-10-13 | SYRS | Grant (A) | — | $0 | EDGAR |
| 2021-02-19 | SYRS | Grant (A) | — | $0 | EDGAR |
| 2020-12-21 | SYRS | Grant (A) | — | $0 | EDGAR |
| 2020-02-14 | SYRS | Grant (A) | — | $0 | EDGAR |
| 2019-02-14 | SYRS | Grant (A) | +87,000 | $0 | EDGAR |